Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis

A “divergent pathway” model for the development of cutaneous melanoma has been proposed. The model hypothesizes that melanomas occurring in people with a low tendency to develop nevi will, on average, arise more commonly on habitually sun‐exposed body sites such as the head and neck. In contrast, people with an inherent propensity to develop nevi will tend to develop melanomas most often on body sites with large melanocyte populations, such as on the back. We conducted a collaborative analysis to test this hypothesis using the original data from 10 case–control studies of melanoma in women (2,406 cases and 3,119 controls), with assessment of the potential confounding effects of socioeconomic, pigmentary and sun exposure‐related factors. Higher nevus count on the arm was associated specifically with an increased risk of melanoma of the trunk (p for trend = 0.0004) and limbs (both upper and lower limb p for trends = 0.01), but not of the head and neck (p for trend = 0.25). The pooled odds ratios for the highest quartile of nonzero nevus count versus none were 4.6 (95% confidence interval (CI) 2.7–7.6) for melanoma of the trunk, 2.0 (95% CI 0.9–4.5) for the head and neck, 4.2 (95% CI 2.3–7.5) for the upper limbs and 3.4 (95% CI 1.5–7.9) for the lower limbs. Aggregate data from these studies suggest that high nevus counts are strongly associated with melanoma of the trunk but less so if at all of the head and neck. This finding supports different etiologic pathways of melanoma development by anatomic site. © 2008 Wiley‐Liss, Inc.

[1]  S. Rosso,et al.  Anthropometric factors and risk of melanoma in women: A pooled analysis , 2007, International journal of cancer.

[2]  M. Berwick,et al.  Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. , 2008, The Journal of investigative dermatology.

[3]  R. Millikan,et al.  Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[4]  V. Siskind,et al.  A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001 , 2007, Cancer Causes & Control.

[5]  J. Stockman,et al.  Distinct Sets of Genetic Alterations in Melanoma , 2007 .

[6]  L. Naldi,et al.  Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. , 2006, The Journal of investigative dermatology.

[7]  H. Höfler,et al.  Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case–control study , 2006, Melanoma research.

[8]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[9]  R. Gallagher,et al.  Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma , 2005, International journal of cancer.

[10]  G. Colditz,et al.  Risk Factors for Melanoma by Body Site , 2005, Cancer Epidemiology Biomarkers & Prevention.

[11]  G. Severi,et al.  Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  Shosuke Ito,et al.  Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status. , 2004, The Journal of investigative dermatology.

[13]  T. Mack,et al.  Skin characteristics and risk of superficial spreading and nodular melanoma (United States) , 2000, Cancer Causes & Control.

[14]  D. Whiteman,et al.  Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies , 2004, Cancer Causes & Control.

[15]  Ajay N. Jain,et al.  Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.

[16]  Daniel Pinkel,et al.  Classifying melanocytic tumors based on DNA copy number changes. , 2003, The American journal of pathology.

[17]  N. Hayward,et al.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.

[18]  S. Harrison,et al.  The Eastern Australian Childhood Nevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. , 2003, Journal of the American Academy of Dermatology.

[19]  S. Rosso,et al.  A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use , 2002, British Journal of Cancer.

[20]  P. Duray,et al.  Neonatal sunburn and melanoma in mice , 2001, Nature.

[21]  J. Barrett,et al.  Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. , 2001, The Journal of investigative dermatology.

[22]  E Demidenko,et al.  Two‐stage methods for the analysis of pooled data , 2001, Statistics in medicine.

[23]  J. Bulliard,et al.  Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. , 2000, International journal of epidemiology.

[24]  J. Bulliard Site‐specific risk of cutaneous malignant melanoma and pattern of Sun exposure in New Zealand , 2000, International journal of cancer.

[25]  J F Aitken,et al.  A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.

[26]  A Biggeri,et al.  Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. , 1999, Journal of the American Academy of Dermatology.

[27]  M. Delgado-Rodríguez,et al.  The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body , 1999, The British journal of dermatology.

[28]  R. Gallagher,et al.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.

[29]  M. Berwick,et al.  Hormonal and reproductive influences and risk of melanoma in women. , 1998, International journal of epidemiology.

[30]  J Cuzick,et al.  Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.

[31]  D. Whiteman,et al.  p53 expression and risk factors for cutaneous melanoma: A case‐control study , 1998, International journal of cancer.

[32]  J. Bulliard,et al.  Comparison of the site distribution of melanoma in New Zealand and Canada , 1997, International journal of cancer.

[33]  K J Dallimore,et al.  Lentigo maligna and lentigo maligna melanoma. , 1997, Journal of the American Academy of Dermatology.

[34]  T. Holford,et al.  Malignant melanoma risk factors by anatomic site: A case‐control study and polychotomous logistic regression analysis , 1996, International journal of cancer.

[35]  J. A. Bishop,et al.  Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. , 1996, British Journal of Cancer.

[36]  D. English,et al.  Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? , 1995, Journal of the American Academy of Dermatology.

[37]  S. Franceschi,et al.  Risk of cutaneous melanoma associated with a family history of the disease , 1995, International journal of cancer.

[38]  Renato Panizzon,et al.  Overall and site‐specific risk of malignant melanoma associated with nevus counts at different body sites: A multicenter case‐control study of the german central malignant‐melanoma registry , 1995, International journal of cancer.

[39]  D. Easton,et al.  Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .

[40]  E. Holly,et al.  Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. , 1995, American journal of epidemiology.

[41]  J. Elwood,et al.  Epidemiological Aspects of Cutaneous Malignant Melanoma , 2012, Developments in Oncology.

[42]  E. White,et al.  Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. , 1994, American journal of epidemiology.

[43]  B. Armstrong The epidemiology of melanoma: where do we go from here? , 1994 .

[44]  M A Weinstock,et al.  Epidemiology of melanoma. , 2017, Cancer treatment and research.

[45]  N. Martin,et al.  Site distribution of cutaneous melanoma in queensland , 1993, International journal of cancer.

[46]  C. Garbe,et al.  Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. , 1992, Journal of the American Academy of Dermatology.

[47]  J. Elwood,et al.  Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. , 1990, International journal of epidemiology.

[48]  S. Kohn UVB irradiation induces melanocyte increase in both exposed and shielded human skin. , 1990, The Journal of investigative dermatology.

[49]  W. Willett,et al.  Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. , 1989, Journal of the National Cancer Institute.

[50]  M. Tucker,et al.  The Danish case‐control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women , 1988, International journal of cancer.

[51]  M. Tucker,et al.  The Danish case‐control study of cutaneous malignant melanoma. I. Importance of host factors , 1988, International journal of cancer.

[52]  C. J. O'doherty,et al.  Site‐specific melanocytic naevus counts as predictors of whole body naevi , 1988, The British journal of dermatology.

[53]  V. Deleo,et al.  Ultraviolet radiation acts as an independent mitogen for normal human melanocytes in culture. , 1988, Pigment cell research.

[54]  C. J. O'doherty,et al.  Benign melanocytic naevi as a risk factor for malignant melanoma. , 1986, British medical journal.

[55]  A. Green,et al.  Hormonal factors and melanoma in women , 1985, The Medical journal of Australia.

[56]  B K Armstrong,et al.  Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. , 1984, Journal of the National Cancer Institute.

[57]  V. Beral,et al.  Malignant melanoma and oral contraceptive use among women in California. , 1977, British Journal of Cancer.

[58]  W. H. Clark,et al.  Lentigo maligna and lentigo-maligna melanoma. , 1969, The American journal of pathology.